Neurological diseases(e.g., Myasthenia gravis, Guillain-Barré syndrome, Chronic inflammatory demyelinating polyneuropathy, Multiple sclerosis)

• Therapeutic plasmapheresis by removing pathogenic substances (anti-acetylcholine receptor antibodies and immune complexes) from patient's plasma by selective adsorption.
• No need for the replacement of plasma, minimizing the risk of infection with hepatitis, AIDS, etc.
• Applicable to patients with protein allergy.